Lifeway Foods, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Lifeway Foods, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Food & Agriculture sector, Lifeway Foods, Inc. has recorded 174 reports. Market capitalisation: €384.5m. The latest transaction was reported on 19 August 2026 (Acquisition). Among the most active insiders: SMOLYANSKY LUDMILA. All data is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Lifeway Foods, Inc. Buy (bullish), based on 2 analysts. Average price target: US$34.50.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,758 of 29,064 companies
FCF yld -4.1%
Earn yld 3.5%
EV/EBITDA 16.8x
ROE 13%
Gross mgn 27%
Net mgn 6.5%
Debt/EBITDA 0.0x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2026
All Executives174 Thresholds0 Prospectus0 Other0
Declarations 174 total
▲ CEO, President and Secretary · Executives · 19 Aug 2026
2,000 shares @ US$25.26 Common Stock, no par value SEC:0001683168-26-006595:0
Canonical exit: 17 Nov 2026 (T+90) ▲ 10% Owner · Executives · 13 Aug 2026
195,616 shares @ US$24.8729 1.25% mcap 79.5% of flow Common Stock, No Par Value SEC:0000919574-26-005601:0
Canonical exit: 11 Nov 2026 (T+90) ▲ 10% Owner · Executives · 14 Aug 2026
15,000 shares @ US$24.6901 0.095% mcap 6.0% of flow Common Stock, No Par Value SEC:0000919574-26-005601:1
Canonical exit: 12 Nov 2026 (T+90) ▲ 10% Owner · Executives · 17 Aug 2026
35,952 shares @ US$24.7809 0.23% mcap 14.5% of flow Common Stock, No Par Value SEC:0000919574-26-005601:2
Canonical exit: 15 Nov 2026 (T+90) ● 10% Stockholder · Executives · 14 Aug 2026
75,000 shares @ US$25.4495 0.51% mcap 8.1% of flow Common Stock SEC144:0001227847-26-000020
▼ 10% Owner · Executives · 14 Aug 2026
29,931 shares @ US$24.89 0.20% mcap 3.4% of flow Common Stock, no par value SEC:0001683168-26-006498:1
▼ 10% Owner · Executives · 14 Aug 2026
45,038 shares @ US$25.82 0.31% mcap 5.4% of flow Common Stock, no par value SEC:0001683168-26-006498:2
▼ 10% Owner · Executives · 14 Aug 2026
31 shares @ US$26.50 0.0002% mcap 0.0% of flow Common Stock, no par value SEC:0001683168-26-006498:3
▼ 10% Owner · Executives · 12 Aug 2026
35,000 shares @ US$28.74 0.27% mcap 4.6% of flow Common Stock, no par value SEC:0001683168-26-006498:0
● 10% Stockholder · Executives · 12 Aug 2026
35,000 shares @ US$28.7366 0.22% mcap 5.4% of flow Common Stock SEC144:0001227847-26-000019
60,000 shares @ US$30.55 0.39% mcap 8.0% of flow Common Stock, no par value SEC:0001683168-26-005734:0
40,000 shares @ US$29.46 0.25% mcap 5.2% of flow Common Stock, no par value SEC:0001683168-26-005734:1
● AFFILIATE · Executives · 22 Jul 2026
100,000 shares @ US$30.75 0.65% mcap 15.5% of flow COMMON SEC144:0001000275-26-000094
▼ 10% Owner · Executives · 15 Jul 2026
42,263 shares @ US$32.32 0.28% mcap 7.8% of flow Common Stock, no par value SEC:0001683168-26-005577:1
▼ 10% Owner · Executives · 15 Jul 2026
24,653 shares @ US$31.51 0.16% mcap 4.4% of flow Common Stock, no par value SEC:0001683168-26-005577:0
● 10% Stockholder · Executives · 15 Jul 2026
6,916 shares @ US$32.0217 0.046% mcap 1.4% of flow Common Stock SEC144:0001227847-26-000017
● 10% Stockholder · Executives · 15 Jul 2026
66,916 shares @ US$32.0217 0.45% mcap 13.9% of flow Common Stock SEC144:0001227847-26-000018
▼ 10% Owner · Executives · 6 Jul 2026
7,984 shares @ US$29.79 0.051% mcap 8.8% of flow Common Stock, no par value SEC:0001683168-26-005411:0
▼ 10% Owner · Executives · 7 Jul 2026
39,098 shares @ US$29.41 0.25% mcap 42.3% of flow Common Stock, no par value SEC:0001683168-26-005411:1
● 10% Stockholder · Executives · 7 Jul 2026
39,098 shares @ US$29.411 0.24% mcap 28.0% of flow Common Stock SEC144:0001227847-26-000016
● 10% Stockholder · Executives · 6 Jul 2026
7,984 shares @ US$29.783 0.050% mcap 5.8% of flow Common Stock SEC144:0001227847-26-000015
● 10% Stockholder · Executives · 30 Jun 2026
50,000 shares @ US$29.567 0.31% mcap 14.0% of flow Common Stock SEC144:0001227847-26-000014
● 10% Stockholder · Executives · 29 Jun 2026
14,542 shares @ US$30.1247 0.092% mcap 4.1% of flow Common Stock SEC144:0001227847-26-000013
● 10% Stockholder · Executives · 26 Jun 2026
111,548 shares @ US$29.2574 0.69% mcap 30.9% of flow Common Stock SEC144:0001227847-26-000012
40,000 shares Common Stock, no par value SEC:0001683168-26-005132:0
25 of 174 declarations
Load more (149 remaining) 关于 Lifeway Foods, Inc. Lifeway Foods, Inc.(股票代码:LWAY)是一家在美国纳斯达克交易所上市的美国公司,总部位于伊利诺伊州莫顿格罗夫。该公司由Michael Smolyansky在家族从东欧移民到美国后于1986年创立,现已发展成为一家专注于发酵乳制品和功能性营养的专业品牌食品公司。其核心业务是可饮用开菲尔,这是该公司的旗舰产品和品牌标识的基础,并辅以其他定位在“更健康”类别的发酵乳制品。([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316825001592/lifeway_i10k-123124.htm?utm_source=openai))
从运营角度来看,Lifeway主要在美国设有生产基地,包括伊利诺伊州莫顿格罗夫、威斯康星州沃基肖、伊利诺伊州奈尔斯和宾夕法尼亚州费城。该公司报告称,绝大部分收入来自其自有工厂生产的产品,这有助于更好地控制质量、供应链执行和产品供应。该公司还利用第三方合作包装商生产某些产品,这为其生产能力提供了额外的灵活性。([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826001886/lifeway_i10k-123125.htm?utm_source=openai))
在竞争方面,Lifeway自称是美国最大的开菲尔生产商和销售商。这一领先地位使其在益生菌、消化健康和功能性食品交叉的市场中拥有独特的利基。尽管竞争格局包括规模更大、资金更雄厚的食品公司,但Lifeway受益于其在开菲尔领域的强大品牌认知度以及专注于不易被综合性乳制品竞争对手复制的产品主张。([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826003839/lifeway_i10q-033126.htm?utm_source=openai))
该公司的主要产品线仍然是可饮用开菲尔,但管理层一直在积极将品牌扩展到相邻类别和渠道。根据该公司的披露,Lifeway正寻求将其品牌扩展到新鲜类别和额外的分销渠道,例如便利店、餐饮服务、俱乐部渠道和药店。这表明其战略旨在扩大家庭渗透率,同时减少对狭窄零售途径的依赖。([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826001886/lifeway_i10k-123125.htm?utm_source=openai))
从地理上看,Lifeway主要仍是美国国内业务,但它也扩大了部分国际分销。该公司表示,其产品目前在美国、墨西哥、阿拉伯联合酋长国、中美洲和加勒比地区销售。与美国市场相比,其国际覆盖范围仍然适中,但这为未来的增长增加了选择性。([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826003838/lifeway_ex9901.htm?utm_source=openai))
近期发展对投资者很重要。在2025财年,Lifeway报告净销售额为212.5亿美元,同比增长13.7%,增长主要得益于品牌可饮用开菲尔销量的增加。该公司还表示,在调整了前一年的客户和物流变化后,可比销售额增长更为强劲。2026年初,该公司报告销售势头持续,并强调了持续的营销投资。与此同时,2025财年包括与达能未经请求的收购提议和股东相关事项相关的高额法律和专业费用,这是一个值得关注的治理和悬而未决的问题。([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826001886/lifeway_i10k-123125.htm?utm_source=openai))